Seres Therapeutics Inc (NASDAQ: MCRB) kicked off on Friday, up 7.36% from the previous trading day, before settling in for the closing price of $0.84. Over the past 52 weeks, MCRB has traded in a range of $0.54-$2.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 477.44% over the last five years. While this was happening, its average annual earnings per share was recorded 86.61%. With a float of $124.81 million, this company’s outstanding shares have now reached $170.20 million.
The firm has a total of 233 workers. Let’s measure their productivity. In terms of profitability, gross margin is -10887.5%, operating margin of -221404.69%, and the pretax margin is -258259.37%.
Seres Therapeutics Inc (MCRB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Seres Therapeutics Inc is 26.90%, while institutional ownership is 23.58%. The most recent insider transaction that took place on Nov 18 ’24, was worth 475. In this transaction Chief Legal Officer and EVP of this company sold 878 shares at a rate of $0.54, taking the stock ownership to the 135,192 shares. Before that another transaction happened on Nov 18 ’24, when Company’s insider sold 977 for $0.54, making the entire transaction worth $528. This insider now owns 32,415 shares in total.
Seres Therapeutics Inc (MCRB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 86.61% per share during the next fiscal year.
Seres Therapeutics Inc (NASDAQ: MCRB) Trading Performance Indicators
Take a look at Seres Therapeutics Inc’s (MCRB) current performance indicators. Last quarter, stock had a quick ratio of 1.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2766.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.19, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Seres Therapeutics Inc (MCRB)
Analysing the last 5-days average volume posted by the [Seres Therapeutics Inc, MCRB], we can find that recorded value of 1.65 million was better than the volume posted last year of 1.31 million. As of the previous 9 days, the stock’s Stochastic %D was 28.77%. Additionally, its Average True Range was 0.07.
During the past 100 days, Seres Therapeutics Inc’s (MCRB) raw stochastic average was set at 46.81%, which indicates a significant decrease from 51.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.87% in the past 14 days, which was lower than the 94.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8100, while its 200-day Moving Average is $0.8834. Now, the first resistance to watch is $0.9355. This is followed by the second major resistance level at $0.9657. The third major resistance level sits at $1.0213. If the price goes on to break the first support level at $0.8497, it is likely to go to the next support level at $0.7941. Now, if the price goes above the second support level, the third support stands at $0.7639.
Seres Therapeutics Inc (NASDAQ: MCRB) Key Stats
The company with the Market Capitalisation of 165.97 million has total of 170,738K Shares Outstanding. Its annual sales at the moment are 126,330 K in contrast with the sum of -113,720 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was 88,780 K.
